• Understand the pathology of psoriatic disease, its manifestations and related comorbidities, indicating why it’s important to treat the disease to target.
• Develop strategies for treating “difficult to treat” forms of psoriasis, including palmoplantar, guttate, genital, oral, nail and scalp psoriasis.
• Select appropriate therapies for moderate to severe psoriatic disease based on current evidence for efficacy, safety and adherence, particularly with regard to difficult to treat cases.

Asking about Genital Psoriasis is Imperative

• Joseph Merola, MD - Brigham & Women's Hospital

• The National Psoriasis Foundation designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The National Psoriasis Foundation designates this enduring material for a maximum of 0.5 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Listen as dermatologist and rheumatologist Dr. Joseph Merola, Brigham and Women’s Hospital in Boston, discusses the complexities of diagnosis, impact, efficacy of treatments and normalization of genital and inverse psoriasis. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.

Andi Agnew, NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.

Joseph Merola, MD has disclosed a relevant financial relationship with a commercial interest in the last 12 months:

• Biogen IDEC, Abbvie, Eli Lilly, Janssen - Advisory Committee Member
• Pfizer - Investigator

• The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

0 %

11/11/2020